Dissociation of cerebrospinal fluid amyloid- and tau levels in patients with prolonged posttraumatic disorders of consciousness

被引:9
|
作者
Bagnato, Sergio [1 ,2 ]
Andriolo, Maria [3 ]
Boccagni, Cristina [1 ,2 ]
Sant'Angelo, Antonino [1 ,2 ]
D'Ippolito, Maria Enza [3 ]
Galardi, Giuseppe [1 ,2 ]
机构
[1] Giuseppe Giglio Fdn, Unit Neurophysiol, Rehabil Dept, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy
[2] Giuseppe Giglio Fdn, Unit Severe Acquired Brain Injuries, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy
[3] Giuseppe Giglio Fdn, Clin Pathol & Microbiol Lab, Cefalu, Italy
关键词
Amyloid beta; traumatic brain injury; total tau; phosphorylated tau; vegetative state; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; DEMENTIA; RISK; BIOMARKERS; INFLAMMATION; CONCORDANCE; POPULATION; PATHOLOGY;
D O I
10.1080/02699052.2018.1479042
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Traumatic brain injury (TBI) is a major risk factor for Alzheimer's disease (AD). Although the mechanisms that lead to AD after a TBI are unclear, we hypothesize that changes in amyloid- (A) metabolism and abnormal tau phosphorylation are reasonable candidates.Objective: To investigate A and tau dynamics in the chronic phase of TBI.Methods: We evaluated A(1-42), total tau (t-tau), and phosphorylated tau (p-tau) levels in the cerebrospinal fluid (CSF) of 15 patients who developed a prolonged disorder of consciousness after a severe TBI (mean time from TBI 271.6176.5days).Results: Reduced A(1-42) levels (median 258pg/ml, range 90-833.6) were observed in 14/15 patients (93.3%) with severe post-TBI disorders of consciousness. These CSF analysis data did not correlate with time since TBI or with the patients' level of consciousness as determined by the Coma Recovery Scale Revised. Normal t-tau levels (median 95.2 pg/ml, range 52-256.9) were found in all patients. Normal p-tau levels (median 22.2pg/ml, range 14-72) were observed in 14/15 patients, with just a single patient having a slightly increased p-tau level.Conclusion: The present findings show that A and tau are differently affected in the chronic phase of severe TBI.
引用
收藏
页码:1056 / 1060
页数:5
相关论文
共 50 条
  • [21] Serum and Cerebrospinal Fluid Uric Acid Levels in Lewy Body Disorders: Associations with Disease Occurrence and Amyloid-β Pathway
    Maetzler, Walter
    Stapf, Anne Kathrin
    Schulte, Claudia
    Hauser, Ann-Kathrin
    Lerche, Stefanie
    Wurster, Isabel
    Schleicher, Erwin
    Melms, Arthur
    Berg, Daniela
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 27 (01) : 119 - 126
  • [22] Prolonged Cerebrospinal Fluid Neurofilament Light Chain Increase in Patients with Post-Traumatic Disorders of Consciousness
    Bagnato, Sergio
    Grimaldi, Luigi M. E.
    Di Raimondo, Giorgio
    Sant'Angelo, Antonino
    Boccagni, Cristina
    Virgilio, Vittorio
    Andriolo, Maria
    JOURNAL OF NEUROTRAUMA, 2017, 34 (16) : 2475 - 2479
  • [23] Mobility and associations with levels of cerebrospinal fluid amyloid β and tau in a memory clinic cohort
    Tangen, Gro Gujord
    Sverdrup, Karen
    Taraldsen, Kristin
    Persson, Karin
    Engedal, Knut
    Bekkhus-Wetterberg, Peter
    Knapskog, Anne-Brita
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [24] A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease
    Katherine W. Turk
    Alexandra Geada
    Victor E. Alvarez
    Weiming Xia
    Jonathan D. Cherry
    Raymond Nicks
    Gaoyuan Meng
    Sarah Daley
    Yorghos Tripodis
    Bertrand R. Huber
    Andrew E. Budson
    Brigid Dwyer
    Neil W. Kowall
    Robert C. Cantu
    Lee E. Goldstein
    Douglas I. Katz
    Robert A. Stern
    Michael L. Alosco
    Jesse Mez
    Ann C. McKee
    Thor D. Stein
    Alzheimer's Research & Therapy, 14
  • [25] Correlation of Specific Amyloid-β Oligomers With Tau in Cerebrospinal Fluid From Cognitively Normal Older Adults
    Handoko, Maureen
    Grant, Marianne
    Kuskowski, Michael
    Zahs, Kathleen R.
    Wallin, Anders
    Blennow, Kaj
    Ashe, Karen H.
    JAMA NEUROLOGY, 2013, 70 (05) : 594 - 599
  • [26] Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment
    Malpas, Charles B.
    Saling, Michael M.
    Velakoulis, Dennis
    Desmond, Patricia
    O'Brien, Terence J.
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (04) : 965 - 975
  • [27] A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease
    Turk, Katherine W.
    Geada, Alexandra
    Alvarez, Victor E.
    Xia, Weiming
    Cherry, Jonathan D.
    Nicks, Raymond
    Meng, Gaoyuan
    Daley, Sarah
    Tripodis, Yorghos
    Huber, Bertrand R.
    Budson, Andrew E.
    Dwyer, Brigid
    Kowall, Neil W.
    Cantu, Robert C.
    Goldstein, Lee E.
    Katz, Douglas I.
    Stern, Robert A.
    Alosco, Michael L.
    Mez, Jesse
    McKee, Ann C.
    Stein, Thor D.
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [28] Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma
    Kontush, A
    Berndt, C
    Weber, W
    Akopyan, V
    Arlt, S
    Schippling, S
    Beisiegel, U
    FREE RADICAL BIOLOGY AND MEDICINE, 2001, 30 (01) : 119 - 128
  • [29] Decreased β-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease
    Sunderland, T
    Linker, G
    Mirza, N
    Putnam, KT
    Friedman, DL
    Kimmel, LH
    Bergeson, J
    Manetti, GJ
    Zimmermann, M
    Tang, B
    Bartko, JJ
    Cohen, RM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (16): : 2094 - 2103
  • [30] Effect of Hemodialysis on Amyloid-β in Cerebrospinal Fluid and Plasma
    Wang, Lin-Chun
    Thwin, Ohnmar
    Chao, Joshua E.
    Patel, Amrish U.
    Debure, Ludovic
    Grobe, Nadja
    Tao, Xia
    Zhang, Hanjie
    Thijssen, Stephan
    Wisniewski, Thomas
    Kotanko, Peter
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 320 - 321